Jul
2026
QSNCC, Bangkok, Thailand
Visit us
stand G26

ZHEJIANG JINGXIN PHARMACEUTICAL CO.LTD.

Exhibitor at CPHI South East Asia 2026
About Us

Jinxin Pharm is a producer of APIs such as Simvastatin, Levofloxacin Hemihydrate, Ciprofloxacin HCL, Gatifloxacin, Enrofloxacin Base&HCL and finished dosage forms such as tablets, capsules and injection. Jingxin pharm hold EDMF & US DMF for all products and formulation factory has got Germany GMP approval.

Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2015
Company types
Manufacturer/Innovator
Contact info
Show contact info Hide contact info
Event information
CPHI South East Asia 2026
  • 08 Jul 2026 - 10 Jul 2026
  • QSNCC, Bangkok, Thailand
  • Visit us at stand G26

Products Featured at CPHI South East Asia 2026

  • Simvastatin Tablet

    Product Simvastatin Tablet

    Jingxin Pharmaceutical offers a wide range of finished products which includes Simvastatin tablet. Contact us for more information.
  • Azithromycin Tablets

    Product Azithromycin Tablets

    Jingxin Pharmaceutical offers a wide range of finished dosage forms products which includes azithromycin tablets. It belongs to macrolides antibiotics category. Contact us for more information.
  • Rosuvastatin Calcium Tablet

    Product Rosuvastatin Calcium Tablet

    Jingxin Pharmaceutical offers a wide range of finished products which includes Rosuvastatin Calcium Tablet. Contact us for more information.
  • Ceftriaxone Sodium For Injection

    Product Ceftriaxone Sodium For Injection

    Jingxin Pharmaceutical offers a wide range of finished dosage forms products which includes ceftriaxone sodium for injection. It belongs to cephalosporin category. Contact us for more information.
  • Ciprofloxacin Lactate

    Product Ciprofloxacin Lactate

    Jingxin Pharmaceutical offers a wide range of finished products which includes  ciprofloxacin lactate. It belongs to APIs category. Contact us for more information.